-
1
المؤلفون: Fortunato Ciardiello, Sara Centonze, A. Diana, Elisena Franzese, Ferdinando De Vita, Michele Orditura, Sandro Pignata
المساهمون: Franzese, E., Diana, A., Centonze, S., Pignata, S., De Vita, F., Ciardiello, F., Orditura, M.
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Veliparib, Mini Review, Population, first line, homologous recombination, lcsh:RC254-282, Olaparib, 03 medical and health sciences, chemistry.chemical_compound, BRCA 1/2 mutation carrier, 0302 clinical medicine, Internal medicine, medicine, Progression-free survival, BRCA 1/2 mutation carriers, education, education.field_of_study, business.industry, PARP inhibitor (PARPi), Combination chemotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Debulking, medicine.disease, ovarian cancer, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, PARP inhibitor, business, Ovarian cancer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91d6650612adf22345d985dbbd5b1e7eTest
https://doi.org/10.3389/fonc.2020.00782Test -
2
المؤلفون: Gennaro Galizia, Angelica Petrillo, Luca Pompella, Rosalaura Sabetta, Iacopo Panarese, Maria Maddalena Laterza, Annalisa Pappalardo, Ferdinando De Vita, Renato Franco, Giuseppe Tirino, Fortunato Ciardiello
المساهمون: Tirino, G., Petrillo, A., Pompella, L., Pappalardo, A., Laterza, M. M., Panarese, I., Sabetta, R., Franco, R., Galizia, G., Ciardiello, F., De Vita, F.
المصدر: Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncologyمصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, gastrointestinal cancer, medicine.medical_treatment, Population, Case Report, Context (language use), Malignancy, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, checkpoint inhibition, Internal medicine, medicine, Gastrointestinal cancer, education, nivolumab, education.field_of_study, business.industry, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Primary tumor, Natural history, 030104 developmental biology, 030220 oncology & carcinogenesis, gastric/GEJ adenocarcinoma, immunotherapy, Nivolumab, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5977183642e06a841856aea12d70ef15Test
https://doi.org/10.3389/fonc.2020.00130Test